Results 241 to 247 of about 16,542 (247)

Efficacy and Safety of Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis Inadequately Controlled by Topical Treatments: A Randomised, Placebo-Controlled, Dose-Ranging Phase 2b Trial

Lancet, The, 2016
Gianluca Pirozzi, Howard Sofen, Diamant Thaçi   +2 more
exaly  

Long-Term Management of Moderate-to-Severe Atopic Dermatitis With Dupilumab and Concomitant Topical Corticosteroids (LIBERTY AD CHRONOS): A 1-Year, Randomised, Double-Blinded, Placebo-Controlled, Phase 3 Trial

Lancet, The, 2017
Gianluca Pirozzi, Christopher Griffiths, Peter Foley   +2 more
exaly  

Dupilumab for Treatment of Atopic Dermatitis

Expert Review of Clinical Pharmacology, 2018
Jerome Srour, Andreas Wollenberg
exaly  

Dupilumab Improves the Molecular Signature in Skin of Patients With Moderate-to-Severe Atopic Dermatitis

Journal of Allergy and Clinical Immunology, 2014
Gianluca Pirozzi, Mayte Suárez-Fariñas, Ana Kostic   +2 more
exaly  

Dupilumab Facial Redness: Positive Effect of Itraconazole

JAAD Case Reports, 2019
Daphne S Bakker, Marjolein de Bruin-Weller, Jorien van der Schaft   +2 more
exaly  

Dupilumab

Reactions Weekly, 2018
openaire   +1 more source

Real-World Efficacy of Dupilumab in Severe, Treatment-Refractory, and Fibrostenotic Patients With Eosinophilic Esophagitis

Clinical Gastroenterology and Hepatology
Evan Dellon, Christopher J Lee
exaly